News Releases »
Find out about the latest news in our business and references to Katan in international publications.
View News Releases: All 2005 2004 2003 2002 2001 2000
6/3/2005 — Long-Awaited Life Sciences Roll-UpStudy Shows Long-Awaited Life Sciences Roll-Up Will Continue, as Pharma and Larger Biotechs Hustle to Fill Dwindling Pipelines Biotech-driven acquisitions will remain at the forefront of deal activity Learn More » |
5/17/2005 — The Long-Awaited Life Sciences Roll-Up ?Katan’s Latest Report—“Outlook for 2005 and Beyond: The Long-Awaited Life Sciences Roll-Up: Will We Have to Wait Another Year? Learn More » |
1/31/2005 — BioExecutive International Biogenerics ArticleBioExecutive International™, published by T&F Informa, is a new business and marketing publication designed specifically for the biotech industry. Seth and Cliff were asked to write an article on biogenerics for the premier issue of this publication ! Learn More » |
4/1/2004 — LabToWallStreet Volume 2 Issue 1L2WS :: LabToWallStreet was founded in 2002 as a quarterly publication for and about New York`s emerging life sciences scene. Seth Yakatan of Katan Associates has been asked to write the feature article for the publication this month. Learn More » |
4/1/2004 — Emerging Markets: Examining the Growth of Biotech in Australia, China and IndiaStan Yakatan will moderate the Emerging Markets panel discussion at the third annual Sachs-Bloomberg Global Biotech Forum for Investing & Partnering in Boston, April 1-2, 2004. Learn More » |
2/4/2004 — Response Biomedical appoints Stan Yakatan to Board of DirectorsResponse Biomedical Corp. (RBM: TSX Venture Exchange), is pleased to announce the appointment of Mr. Stan Yakatan, Chairman of US-based Katan Associates International, to the Company`s Board of Directors. Learn More » |
11/1/2003 — Biotechnology Investment Today: In Coversation with.......Stan YakatanThe Winter 2003 issue of Biotechnology Investment Today featured this article on Stan. In it he discusses the role of M&A igloban the overall development of the biotechnology sector. Learn More » |
9/29/2003 — LifePoint Announces Appointment of Chairman of the BoardLifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, announced today the appointment of director Stan Yakatan as the new non-employee Chairman of the Board of Directors. Learn More » |
6/25/2003 — Dermatrends Engages Katan to Seek PartnershipsDermatrends, Inc., a privately held research and development company devoted to transdermal and other drug delivery technologies has engaged Katan to assist it in developing licensing opportunities for its transdermal technology. Learn More » |
6/1/2003 — Biotechnology Investment Today: In conversation with....Stan YakatanThe Spring 2003 issue of Biotechnology Investment Today featured this article on Stan. In it he discusses global development of biotechnology. Learn More » |
2/10/2003 — Katan and BSI Announce Strategic Partnership for AustraliaKatan International and BSI have decided to join forces to provide a depth of experience to biotech companies. Learn More » |
2/3/2003 — Genetronics Stockholders Approve BTX SaleGenetronics Biomedical Corporation, (GEB) announced today the completion of the sale of substantially all of the properties and assets that are primarily used in its BTX Division. Katan acted as GEB`s principal advisor on this transaction. Learn More » |
8/23/2002 — Katan Associates International - BrochureFind out more about Katan`s services including - Strategy Formulation - International Business Development - Investment Banking/Venture Capital - Government & Industry Advisory - US Listing Services download now Learn More » |
7/31/2002 — Millipore Acquires Chromatography Media CompanyKatan advises CPG on its successful sale to Milipore. Learn More » |
6/24/2002 — Stressgen Biotechnologies And Roche Announce Global Development And Marketing Collaboration Valued Up To $204 Million U.S.Stressgen Biotechnologies Corporation (TSX:SSB) and Roche announced today that they have entered into a Collaboration Agreement for the co-development and comercialization of Stressgen`s innovative proprietary heat shock protein fusion product candidate. Learn More » |
6/9/2002 — $11.5 Million Capital Pool for Biomedical ResearchThe Premier, Steve Bracks, today announced the launch of a $11.5 milion capital pool to commercialise biomedical research in Victoria. Learn More » |
5/1/2002 — BioNetwork, Issue 8, May 2002: Global Comment, Global Outlook for M&A ActivityBioNetwork is a bimonthly pubilcation circulated amongst 1700 biotech players in Australasia. In this issue, Seth has been asked to provide insight on the state of global M&A activity in the Life Sciences sector. Learn More » |
3/28/2002 — New Website Launch - KatanAssociates.comAfter several requests from our friends and clients to have a more informative and user freindly website, Katan formally announces the launch of our new site. Learn More » |
7/23/2001 — What`s New In Victoria: Biotech Advisors Choose MelbourneThe Age, a leading Melbourne based newspaper, recently published an article regarding Katan decision to open an office in Melbourne Learn More » |
1/1/2001 — Risk and Reward Encouraging Innovation In VictoriaA publication distributed by the Victorian State Government, this issue of Innovation contains an article quoting Katan`s Melbourne Partner, Dr. Russell Joshua, and features and article on Katan`s Chairman, Stan Yakatan. Learn More » |
6/1/2000 — Science Technology InnovationScience Technology and Innovation: a Whole of Government and Whole of State Initiative Learn More » |
